Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
OVERLAP
44%
OVERLAP
BY WEIGHT
13
# OF OVERLAPPING
HOLDINGS
MEDX
27
HOLDINGS
48%
ALSO IN FTXH
FTXH
50
HOLDINGS
27%
ALSO IN MEDX
SECTOR DRIFT (MEDX minus FTXH)
OVERLAPPING HOLDINGS
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in MEDX |
Weight in FTXH |
Overlap | |
|---|---|---|---|---|
 |
ABBVIE INC | 8.9% | 6.9% | 6.9% |
|
ELI LILLY & CO | 17.5% | 6.8% | 6.8% |
|
JOHNSON & JOHNSON | 6.0% | 6.9% | 6.0% |
|
MERCK & CO. INC. | 4.6% | 7.6% | 4.6% |
|
BRISTOL-MYERS SQUIBB CO | 4.6% | 6.7% | 4.6% |
MEDX Overweight Relative to FTXH
|
ELI LILLY & CO | 10.7% |
 |
NOVARTIS AG-ADR | 7.0% |
 |
ASTRAZENECA PLC | 4.2% |
 |
ALKERMES PLC | 3.7% |
|
IONIS PHARMACEUTICALS, INC. | 3.0% |
|
CRISPR THERAPEUTICS AG | 2.7% |
|
ALNYLAM PHARMACEUTICALS INC | 2.7% |
|
GLAXOSMITHKLINE PLC-SPON ADR | 2.5% |
|
ABBVIE INC | 2.0% |
|
BEAM THERAPEUTICS, INC. | 1.3% |
MEDX Underweight Relative to FTXH
|
VERTEX PHARMACEUTICALS INC | -3.5% |
|
CARDINAL HEALTH INC | -3.4% |
|
VIATRIS, INC. | -3.3% |
|
GILEAD SCIENCES INC | -3.2% |
|
MERCK & CO. INC. | -3.0% |
|
INCYTE CORP | -2.5% |
|
JAZZ PHARMACEUTICALS PLC | -2.3% |
|
ILLUMINA INC | -2.3% |
|
UNITED THERAPEUTICS CORP | -2.3% |
|
BRISTOL-MYERS SQUIBB CO | -2.1% |